UNSPSC 51292607: Clorazepate monopotassium or potassium clorazepate

This classification denotes a benzodiazepine with the molecular structure C16H10CLN2O3.K, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, MS63G8NQUI chemically known as 1h-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt, but more commonly known as clorazepate monopotassium, which bears US NIH Compound Identifier 22312. European Medicines Agency schedules Clorazepate monopotassium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01369MIG.

UNSPSC 51292607 Clorazepate monopotassium or potassium clorazepate is a Commodity code whose nominal scope — a specific benzodiazepine pharmaceutical — does not align with recent state and local solicitation activity. The single recent opportunity posted under this code involves procurement of naloxone and drug deactivation systems, products unrelated to clorazepate. The mismatch suggests either a tagging error in the source record or that state and local procurement offices are using this code outside its intended pharmaceutical taxonomy. State and local governments soliciting under this code are not consistently buying the pharmaceutical named in the code's official description.

Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The opportunity required electronic bid submission through the county's e-Procurement Portal, E-Verify compliance, drug-free workplace certification, and a three-month probationary period. The contract was potentially funded through FEMA and included a two-year initial term with a one-year renewal option. Beyond this single solicitation, the code shows no recent relevant state and local procurement activity aligned with its clorazepate pharmaceutical scope.